Other symptoms you or a partner may notice include: Obstructive sleep apnea (OSA). This is the most common type of sleep ...

A common childhood epilepsy drug has the potential to change the lives of millions of people who suffer from sleep apnea, as ...

Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive ...

Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...

A new survey shows that more than half of people diagnosed with obstructive sleep apnea (OSA) aren’t satisfied with their ...

An early-stage clinical trial found that sulthiame reduced sleep apnea 40 percent to 50 percent compared to placebo.

There are two diagnoses possible, consisting of obstructive sleep apnea (OSA) and central sleep apnea (CSA). OSA occurs when ...

Sulthiame, known for treating epilepsy, shows potential in a clinical trial to alleviate obstructive sleep apnoea symptoms, ...

Sulthiame demonstrated significant reductions in respiratory pauses and improvements in oxygen levels during sleep, offering ...

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...

However, yesterday the FDA approved the new Apple Watch (a.k.a. the Apple Watch Series 10) to detect symptoms of sleep apnea ...

Withings has received a clearance from the FDA for what it describes as the first device that can help diagnose a person with ...